Fidani Paola, De Ioris Maria Antonietta, Serra Annalisa, De Sio Luigi, Ilari Ilaria, Cozza Raffaele, Boldrini Renata, Milano Giuseppe Maria, Garrè Maria Luisa, Donfrancesco Alberto
Division of Pediatric Oncology Unit, Ospedale Pediatrico Bambino Gesù, Piazza S.Onofrio 4, Rome, 00100, Italy.
J Neurooncol. 2009 Apr;92(2):177-83. doi: 10.1007/s11060-008-9750-y. Epub 2008 Nov 29.
Atypical Teratoid/Rhabdoid Tumour is a rare and aggressive childhood tumour. The outcome of a series treated with the same multimodal strategy was reported.
The patients were treated with surgery, 2 courses of ifosfamide/carboplatin/etoposide(ICE), 2 courses of cyclophosphamide/etoposide/carboplatino/thiotepa (CECAT) or 2 other ICE courses, high dose chemotherapy (HDC) and radiotherapy.
Eight patients underwent primary surgery achieving a complete removal in 3. Progressive disease (PD) occurred in 2/8 patients during ICE courses and in 3/4 during CECAT courses. After 4 courses 5 patients presented a PD. HDC was performed in 3 patients followed by local radiotherapy. The Kaplan Meier OS and EFS probability at 5 years are, respectively, 50% (CI 11-80%) and 33% (CI 6-66%).
A strategy based on surgery, including a second surgical look, and on radiotherapy appears the best option. ICE regimen and HDC correlate with good prognosis in some patients but this approach needs further evaluation.
非典型畸胎样/横纹肌样瘤是一种罕见且侵袭性强的儿童肿瘤。报告了一组采用相同多模式策略治疗的结果。
患者接受了手术、2个疗程的异环磷酰胺/卡铂/依托泊苷(ICE)、2个疗程的环磷酰胺/依托泊苷/卡铂/塞替派(CECAT)或另外2个ICE疗程、大剂量化疗(HDC)和放疗。
8例患者接受了初次手术,3例实现了完全切除。2/8例患者在ICE疗程期间出现疾病进展(PD),3/4例在CECAT疗程期间出现PD。4个疗程后,5例患者出现PD。3例患者接受了HDC,随后进行了局部放疗。5年时的Kaplan Meier总生存率(OS)和无事件生存率(EFS)概率分别为50%(95%CI 11 - 80%)和33%(95%CI 6 - 66%)。
基于手术(包括二次手术探查)和放疗的策略似乎是最佳选择。ICE方案和HDC在一些患者中与良好预后相关,但这种方法需要进一步评估。